EMBECTA CORP. Transfer of Financial Assets Accounted for as Sales, Amount Derecognized
EMBECTA CORP. (EMBC) had Transfer of Financial Assets Accounted for as Sales, Amount Derecognized of $167.20 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Transfers and Servicing of Financial Assets
us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized · last filed 2026-08-07
- 2026-06-30: Transfer of Financial Assets Accounted for as Sales, Amount Derecognized $167.20M.
- 2026-03-31: Transfer of Financial Assets Accounted for as Sales, Amount Derecognized $120.30M.
- 2025-12-31: Transfer of Financial Assets Accounted for as Sales, Amount Derecognized $56.00M.
- 2025-09-30: Transfer of Financial Assets Accounted for as Sales, Amount Derecognized $63.20M.
| Period end | Transfer of Financial Assets Accounted for as Sales, Amount Derecognized |
|---|---|
| 2026-06-30 | $167.20M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $120.30M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $56.00M 10-Q · filed 2026-02-05 |
| 2025-09-30 | $63.20M 10-K · filed 2025-11-25 |
| 2025-06-30 | $26.20M 10-Q · filed 2025-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |